S&P Global to Spin Off Mobility Global on July 1
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 26 2026
0mins
S&P Global (SPGI) is spinning off Mobility Global (MBGL) in a transaction expected to be completed July 1. Core Laboratories (CLB) is no longer representative of the small-cap market space.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CLB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CLB
Wall Street analysts forecast CLB stock price to rise
1 Analyst Rating
0 Buy
0 Hold
1 Sell
Moderate Sell
Current: 11.090
Low
11.50
Averages
11.50
High
11.50
Current: 11.090
Low
11.50
Averages
11.50
High
11.50
About CLB
Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
S&P SmallCap 600 Index Changes Announced
- New Addition: On July 1, 2026, Gulfport Energy (Ticker: GPORE) will be added to the S&P SmallCap 600 Index, indicating recognition in the energy sector and likely attracting increased investor interest in its market performance.
- Removal of Company: On the same day, Select Medical Holdings (Ticker: SEM) will be removed from the S&P SmallCap 600 Index, which may negatively impact its stock price, reflecting market concerns about its future growth potential.
- New Addition: On July 2, 2026, Mobility Global (Ticker: MBGL) will join the S&P SmallCap 600 Index, signaling growth potential in the industrial sector, which could enhance its market visibility and investment appeal.
- Removal of Company: On the same day, Core Laboratories (Ticker: CLB) will be removed from the S&P SmallCap 600 Index, potentially leading to decreased liquidity and reflecting market caution regarding its business outlook.
See More
Changes to S&P SmallCap 600 Index Components Announced
- Component Changes: The S&P SmallCap 600 Index will see Gulfport Energy (Ticker: GPOR) replace Select Medical Holdings (Ticker: SEM) effective July 1, 2026, as the latter is being acquired, highlighting market focus on small-cap liquidity.
- Industry Dynamics: Mobility Global (Ticker: MBGL) will join the S&P SmallCap 600 Index on July 2, 2026, replacing Core Laboratories (Ticker: CLB), which is removed for no longer representing the small-cap market, reflecting structural changes in the industry and investor interest in emerging companies.
- Timing of Changes: These changes will take effect prior to the market open, marking a dynamic adjustment to the S&P SmallCap 600 Index aimed at maintaining its representativeness and market relevance, ensuring investors have access to the latest market information.
- Market Impact: The adjustments to these components not only affect the stock performance of the involved companies but may also prompt investors to reassess their investment strategies in the small-cap market, further driving market liquidity and activity.
See More
Valuation Analysis of Energy Stocks: Core Labs and Others Lead
- Valuation Grade Overview: Core Laboratories (CLB) is identified as the most expensive stock among energy companies with market caps below $2B, indicating a high valuation relative to peers, which may influence investor purchasing decisions.
- W&T Offshore Performance: While W&T Offshore (WTI) shows strong fundamentals, valuation and technical indicators raise caution in the market, suggesting that despite robust profitability, investors should remain aware of potential risks.
- Deep Yellow's Market Position: Deep Yellow (DYLLF) holds a valuation grade of D, reflecting its relative disadvantage in the market, which may limit its ability to attract investors and impact future financing and expansion opportunities.
- Industry-Wide Trends: Overall, energy stocks with market caps below $2B are facing valuation pressures, prompting investors to carefully assess the financial health and market outlook of these companies to make more informed investment strategies.
See More
Core Laboratories Shares Drop 7.4% After Disappointing Q1 2026 Results
- Significant Earnings Decline: Core Laboratories reported Q1 earnings per share of $0.06, a 76.92% miss from the expected $0.26, indicating a substantial drop in profitability that could undermine investor confidence.
- Revenue Continues to Fall: The company's revenue for the quarter was $121.8 million, reflecting a 12% sequential decline and a 1% year-over-year decrease, suggesting weak market demand and operational challenges that may lead to downward revisions in future earnings expectations.
- External Factors Impacting Performance: Severe cold weather in North America and a storm in the Mediterranean disrupted client activities and temporarily closed manufacturing facilities, exacerbating revenue and profit margin pressures, highlighting the company's vulnerability to natural disasters.
- Increased Stock Volatility: Core Laboratories has experienced 25 moves greater than 5% over the past year, and while the current stock drop is significant, the market's perception of its long-term outlook may not fundamentally change, prompting investors to carefully assess buying opportunities.
See More
Core Laboratories Q1 Results Exceed Expectations Despite Sales Decline
- Performance Overview: Core Laboratories reported Q1 CY2026 revenue of $121.8 million, slightly exceeding analyst expectations of $121 million, but reflecting a 1.4% year-on-year decline, indicating challenges in the market.
- Profit Decline: The adjusted EPS of $0.06 fell significantly short of the $0.11 expected by analysts, representing a 45.5% miss, which highlights the pressure and rising costs faced by the company in its operations.
- Market Environment Impact: Disruptions from the Middle East conflict and severe weather in North America and Europe led to project delays and reduced client activity, particularly affecting the Reservoir Description segment, with the CEO noting a situation of “all costs and no revenue.”
- Future Outlook: Despite ongoing supply chain volatility and rising raw material costs, management anticipates a gradual recovery in client activity as geopolitical conditions stabilize, driving increased demand for reservoir diagnostics and production optimization technologies.
See More
Core Laboratories Q1 2026 Earnings Call Insights
- Revenue Decline: Core Laboratories reported Q1 revenue of $121.8 million, reflecting a 12% decrease from the previous quarter and a 1% year-over-year decline, indicating significant business disruption due to the Middle East conflict, prompting a downward revision of the 2026 Q1 revenue and earnings forecast.
- Shareholder Returns: Despite challenges, the company returned cash to shareholders through quarterly dividends and repurchased over 51,000 shares valued at $900,000, demonstrating a continued commitment to shareholder interests amid operational difficulties.
- Future Outlook: Management projects Q2 2026 revenue to range between $123 million and $131 million, maintaining a cautiously optimistic view on gradual operational improvement despite geopolitical uncertainties impacting forecasting accuracy.
- Operational Risks: Executives highlighted that the volatility and unpredictability of the conflict will affect operations, particularly regarding rising raw material costs and supply chain disruptions, which could lead to demand uncertainties and operational inefficiencies.
See More
S&P SmallCap 600 Index Changes Announced
- New Addition: On July 1, 2026, Gulfport Energy (Ticker: GPORE) will be added to the S&P SmallCap 600 Index, indicating recognition in the energy sector and likely attracting increased investor interest in its market performance.
- Removal of Company: On the same day, Select Medical Holdings (Ticker: SEM) will be removed from the S&P SmallCap 600 Index, which may negatively impact its stock price, reflecting market concerns about its future growth potential.
- New Addition: On July 2, 2026, Mobility Global (Ticker: MBGL) will join the S&P SmallCap 600 Index, signaling growth potential in the industrial sector, which could enhance its market visibility and investment appeal.
- Removal of Company: On the same day, Core Laboratories (Ticker: CLB) will be removed from the S&P SmallCap 600 Index, potentially leading to decreased liquidity and reflecting market caution regarding its business outlook.
See More
Changes to S&P SmallCap 600 Index Components Announced
- Component Changes: The S&P SmallCap 600 Index will see Gulfport Energy (Ticker: GPOR) replace Select Medical Holdings (Ticker: SEM) effective July 1, 2026, as the latter is being acquired, highlighting market focus on small-cap liquidity.
- Industry Dynamics: Mobility Global (Ticker: MBGL) will join the S&P SmallCap 600 Index on July 2, 2026, replacing Core Laboratories (Ticker: CLB), which is removed for no longer representing the small-cap market, reflecting structural changes in the industry and investor interest in emerging companies.
- Timing of Changes: These changes will take effect prior to the market open, marking a dynamic adjustment to the S&P SmallCap 600 Index aimed at maintaining its representativeness and market relevance, ensuring investors have access to the latest market information.
- Market Impact: The adjustments to these components not only affect the stock performance of the involved companies but may also prompt investors to reassess their investment strategies in the small-cap market, further driving market liquidity and activity.
See More
Valuation Analysis of Energy Stocks: Core Labs and Others Lead
- Valuation Grade Overview: Core Laboratories (CLB) is identified as the most expensive stock among energy companies with market caps below $2B, indicating a high valuation relative to peers, which may influence investor purchasing decisions.
- W&T Offshore Performance: While W&T Offshore (WTI) shows strong fundamentals, valuation and technical indicators raise caution in the market, suggesting that despite robust profitability, investors should remain aware of potential risks.
- Deep Yellow's Market Position: Deep Yellow (DYLLF) holds a valuation grade of D, reflecting its relative disadvantage in the market, which may limit its ability to attract investors and impact future financing and expansion opportunities.
- Industry-Wide Trends: Overall, energy stocks with market caps below $2B are facing valuation pressures, prompting investors to carefully assess the financial health and market outlook of these companies to make more informed investment strategies.
See More
Core Laboratories Shares Drop 7.4% After Disappointing Q1 2026 Results
- Significant Earnings Decline: Core Laboratories reported Q1 earnings per share of $0.06, a 76.92% miss from the expected $0.26, indicating a substantial drop in profitability that could undermine investor confidence.
- Revenue Continues to Fall: The company's revenue for the quarter was $121.8 million, reflecting a 12% sequential decline and a 1% year-over-year decrease, suggesting weak market demand and operational challenges that may lead to downward revisions in future earnings expectations.
- External Factors Impacting Performance: Severe cold weather in North America and a storm in the Mediterranean disrupted client activities and temporarily closed manufacturing facilities, exacerbating revenue and profit margin pressures, highlighting the company's vulnerability to natural disasters.
- Increased Stock Volatility: Core Laboratories has experienced 25 moves greater than 5% over the past year, and while the current stock drop is significant, the market's perception of its long-term outlook may not fundamentally change, prompting investors to carefully assess buying opportunities.
See More
Core Laboratories Q1 Results Exceed Expectations Despite Sales Decline
- Performance Overview: Core Laboratories reported Q1 CY2026 revenue of $121.8 million, slightly exceeding analyst expectations of $121 million, but reflecting a 1.4% year-on-year decline, indicating challenges in the market.
- Profit Decline: The adjusted EPS of $0.06 fell significantly short of the $0.11 expected by analysts, representing a 45.5% miss, which highlights the pressure and rising costs faced by the company in its operations.
- Market Environment Impact: Disruptions from the Middle East conflict and severe weather in North America and Europe led to project delays and reduced client activity, particularly affecting the Reservoir Description segment, with the CEO noting a situation of “all costs and no revenue.”
- Future Outlook: Despite ongoing supply chain volatility and rising raw material costs, management anticipates a gradual recovery in client activity as geopolitical conditions stabilize, driving increased demand for reservoir diagnostics and production optimization technologies.
See More
Core Laboratories Q1 2026 Earnings Call Insights
- Revenue Decline: Core Laboratories reported Q1 revenue of $121.8 million, reflecting a 12% decrease from the previous quarter and a 1% year-over-year decline, indicating significant business disruption due to the Middle East conflict, prompting a downward revision of the 2026 Q1 revenue and earnings forecast.
- Shareholder Returns: Despite challenges, the company returned cash to shareholders through quarterly dividends and repurchased over 51,000 shares valued at $900,000, demonstrating a continued commitment to shareholder interests amid operational difficulties.
- Future Outlook: Management projects Q2 2026 revenue to range between $123 million and $131 million, maintaining a cautiously optimistic view on gradual operational improvement despite geopolitical uncertainties impacting forecasting accuracy.
- Operational Risks: Executives highlighted that the volatility and unpredictability of the conflict will affect operations, particularly regarding rising raw material costs and supply chain disruptions, which could lead to demand uncertainties and operational inefficiencies.
See More
